Lexaria Announces 2020 Annual and Special Meeting Results
Kelowna, British Columbia – June 24, 2020 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) announces the results of the 2020 Annual and Special Meeting (the…
Lexaria Bioscience Applies for NIH Grant for COVID-19 Therapy Studies and Receives New Expanded Health Canada License
KELOWNA, BC / June 18, 2020 / Lexaria Bioscience Corp. (OTCQX: LXRP)(CSE: LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has submitted a grant…
Lexaria Bioscience Engages PCG Advisory, Inc, to Provide Investor Relations Services
KELOWNA, BC / June 1, 2020 / Lexaria Bioscience Corp. (OTCQX: LXRP)(CSE: LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has retained PCG Advisory,…
Lexaria Bioscience Confirms Closing of US$2,039,228 Private Placement
KELOWNA, BC / ACCESSWIRE / May 11, 2020 / Lexaria Bioscience Corp. (OTCQX: LXRP)(CSE: LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today confirms that its…
Lexaria Bioscience Announces Over US$2,000,000 Private Placement
KELOWNA, BC / ACCESSWIRE / May 4, 2020 / Lexaria Bioscience Corp. (OTCQX: LXRP)(CSE: LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it…
Lexaria Receives Notice of Allowance for New Patent and Awards Stock Options
Kelowna, British Columbia– April 23, 2020 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, has received a Notice of Allowance…
Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19
Kelowna, British Columbia – April 21, 2020 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, has filed an important…
Lexaria Bioscience Expands Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment
Kelowna, British Columbia – March 23, 2020 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, has expanded the scope…
Lexaria Bioscience Begins Coronavirus COVID-19 Drug Delivery Program
Kelowna, British Columbia– March 19, 2020 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery technology, announces it is commencing a…
Lexaria Bioscience Announces Warrant Issuance
Kelowna, British Columbia– March 16, 2020 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company”), a global innovator in drug delivery platforms, announces that on March 16, 2020 it…